Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics By admin - November 8, 2023 35 This enhanced article is exclusively for Pα+ subscribers. Head to our Join page to learn more, or sign in to your account. Source RELATED ARTICLESMORE FROM AUTHOR Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA The Problems We Will Be Lucky to Have Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
